NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/16/2024
Back to search
Official data from USPTO
NANOSTRING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
11/16/2024
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
03/28/2017
Registration date
08/07/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2024
Last transaction
11/16/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/30/2017
First use in commerce
08/30/2017
Drawing code
3
Owner type
03
Owner location
BILLERICA, MA, US
Examiner
PAPALE,LISA ANNE
Current location
Historical data usage
Mark description
The mark consists of the word "nanoString" with a line below the word containing circles.
Holders and representatives
Holders
BRUKER SPATIAL BIOLOGY, INC.
NanoString Technologies, Inc.
Representatives
Alyssa Worsham WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagentsslidessolid matrix materialsmicrofluidic devices and support documentationinstructional manualstherefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory usereagents for proteomicsRNA transcription and microRNA expression profilingsmall- molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectorsreagents for scientific or medical research usediagnostic preparations and reagents for scientific or research usesRNA transcription profilingproteomicsclinical diagnosticsenvironmental monitoringbiosurveillanceagricultural inspectionforensic testing of samples containing microorganisms or human fluidssmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; test kitsconsisting of chemical preparations for scientific purposesin particular for the detectiondiagnosisprogress monitoring and progress prediction of diseasesincluding inflammationsinfectionsdisorders of the central nervous systemscardiovascularneurologicalendocrineautoimmune and genetic disorders and cancers; assaysreagentsenzymespolymerasesbuffers and nucleotideskits comprised thereofall for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namelydiagnostic reagents for scientific in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall- molecule analysissingle nucleotide polymorphisms analysisDNA sequencing
Class 5
Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogenscomprising primarily reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample typeequipmentmedical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample typesold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipmentmedical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profilingproteomicssmall molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namelymedical diagnostic reagents for RNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; tests designed to isolate and extract cells for genetic analysisreagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Class 42
Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiringanalyzing and managing biological and genetic informationin the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicinemeasuring apparatus for use in product research and developmentseparation and purification processesenvironmental and testing processesindustrial quality control processes; developing systems for acquiringanalyzingmanaging biological and genetic information in the fields of diagnostic reagentsforensicsmedicinegeneticsenvironment; researchdesigndevelopment services for others in the fields of diagnostic reagentscompounds and devicesmeasuring apparatus for use in product research and developmentseparation and purification processesenvironmental and testing processes and industrial quality control processes; chemical screening analysis for others
Publications
History of USPTO decisions and trademark events.
35 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/16/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/16/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/04/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/07/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/18/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/29/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/09/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/08/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
06/08/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/08/2018
IUAF
USE AMENDMENT FILED
06/04/2018
DRRR
DIVISIONAL REQUEST RECEIVED
06/04/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/04/2018
EISU
TEAS STATEMENT OF USE RECEIVED
06/04/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2018
EX1G
SOU EXTENSION 1 GRANTED
03/30/2018
EXT1
SOU EXTENSION 1 FILED
03/30/2018
EEXT
SOU TEAS EXTENSION RECEIVED
03/30/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/17/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2017
PUBO
PUBLISHED FOR OPPOSITION
08/22/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/22/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/22/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/22/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/22/2017
DOCK
ASSIGNED TO EXAMINER
06/20/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2017
NWAP
NEW APPLICATION ENTERED
03/31/2017
Continuous trademark protection
Get notified about every new filing that threatens NANOSTRING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.